Department of Biosciences, School of Science, Indrashil University, Rajpur, Mehsana, Gujarat, India.
Department of Biosciences, School of Science, Indrashil University, Rajpur, Mehsana, Gujarat, India.
Prog Mol Biol Transl Sci. 2024;205:213-220. doi: 10.1016/bs.pmbts.2024.03.020. Epub 2024 Apr 4.
Currently, millions of drugs and their licence have been expired or will be expiring in near future. Therefore, existing USFDA approved drug can be used for treating another disease. The above-mentioned approach falls under the category of drug repurposing. Drug repurposing is an alternative strategy for finding new applications of existing USFDA approved drugs. Identification of a novel drug target is one of the go to way for drug repurposing so that new therapeutic applications of USFDA approved drugs could be determined. Recent advances in computational biology and bioinformatics can help to accelerate the same. Drug repurposing can save time and resource as compared to discovery of an entirely new drug molecule. In this chapter, we explore different strategies for discovery of a novel drug target and its uses for drug repurposing to treat disease.
目前,数以百万计的药物及其许可证已经过期或即将在不久的将来过期。因此,现有的美国食品和药物管理局批准的药物可以用于治疗另一种疾病。上述方法属于药物再利用的范畴。药物再利用是为现有美国食品和药物管理局批准的药物寻找新用途的替代策略。确定新的药物靶点是药物再利用的一种常用方法,以便确定美国食品和药物管理局批准的药物的新治疗应用。计算生物学和生物信息学的最新进展可以帮助加速这一过程。与发现全新的药物分子相比,药物再利用可以节省时间和资源。在本章中,我们探讨了发现新的药物靶点的不同策略及其在药物再利用治疗疾病中的应用。